Followers | 7 |
Posts | 1577 |
Boards Moderated | 0 |
Alias Born | 02/27/2014 |
Tuesday, December 16, 2014 3:37:33 PM
Let's face it....allowed compensation in stocks is negotiated between Frost and other lead investors on one side and the management and board on the other side.
It is all about give and take, each side trying to achieve what it wants under a fair deal.
So, these initial levels of dilution might not last forever....unless Musclepharm finances all it's projects through Frost and co.
Even if that was the case, Frost usually brings a lot to the table...so it is not all bad. However, I don't think that is the case as Brad seems to be very much against raising more capital at a steep discount.
So, our fears might be misguided and Musclepharm might treat shareholders better than what we think. The share price is close to $8...it should matter to the management after a year with 80% sales growth and lots of shares awarded to management.
In 2015, the management is forced to deliver something to shareholders to survive.
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM